Authors: KWEI GY NOVAK LB HETTRICK LA REISS ER OSTOVIC D LOPER AE LUI CY HIGGINS RJ CHEN IW LIN JH

Citation: Gy. Kwei et al., REGIOSPECIFIC INTESTINAL-ABSORPTION OF THE HIV PROTEASE INHIBITOR L-735,524 IN BEAGLE DOGS, Pharmaceutical research, 12(6), 1995, pp. 884-888

Authors: OSTOVIC D BRENNER GS

Citation: D. Ostovic et Gs. Brenner, DEVELOPMENT OF SUBCUTANEOUS AND INTRAMUSCULAR FORMULATIONS OF CALCIUMALENDRONATE SALTS, Drug development and industrial pharmacy, 21(10), 1995, pp. 1157-1169

Authors: LIN JH CHEN IW VASTAG KJ OSTOVIC D

Citation: Jh. Lin et al., PH-DEPENDENT ORAL ABSORPTION OF L-735,524, A POTENT HIV PROTEASE INHIBITOR, IN RATS AND DOGS, Drug metabolism and disposition, 23(7), 1995, pp. 730-735

Authors: KIM BM VACCA JP GUARE JP HANIFIN CM MICHELSON SR DARKE PL ZUGAY JA EMINI EA SCHLEIF W LIN JH CHEN IW VASTAG K OSTOVIC D ANDERSON PS HUFF JR

Citation: Bm. Kim et al., A NEW HYDROXYETHYLAMINE CLASS OF HIV-1 PROTEASE INHIBITORS WITH HIGH ANTIVIRAL POTENCY AND ORAL BIOAVAILABILITY, Bioorganic & medicinal chemistry letters, 4(19), 1994, pp. 2273-2278

Authors: VACCA JP DORSEY BD SCHLEIF WA LEVIN RB MCDANIEL SL DARKE PL ZUGAY J QUINTERO JC BLAHY OM ROTH E SARDANA VV SCHLABACH AJ GRAHAM PI CONDRA JH GOTLIB L HOLLOWAY MK LIN J CHEN IW VASTAG K OSTOVIC D ANDERSON PS EMINI EA HUFF JR

Citation: Jp. Vacca et al., L-735,524 - AN ORALLY BIOAVAILABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Proceedings of the National Academy of Sciences of the United Statesof America, 91(9), 1994, pp. 4096-4100

Authors: DORSEY BD LEVIN RB MCDANIEL SL VACCA JP GUARE JP DARKE PL ZUGAY JA EMINI EA SCHLEIF WA QUINTERO JC LIN JH CHEN IW HOLLOWAY MK FITZGERALD PMD AXEL MG OSTOVIC D ANDERSON PS HUFF JR

Citation: Bd. Dorsey et al., L-735,524 - THE DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR, Journal of medicinal chemistry, 37(21), 1994, pp. 3443-3451